| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |